3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

      3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

PR Newswire

SHENYANG, China, April 25, 2013

SHENYANG, China, April 25, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX)
("3SBio" or the "Company"), a leading China-based biotechnology company
focused on researching, developing, manufacturing and marketing
biopharmaceutical products, today announced that, at the duly convened
extraordinary general meeting of shareholders ("EGM") held at 10:00am Beijing
time on April 25, 2013, Dr. Jing Lou, as the chairman of EGM, declared that
EGM be adjourned to a later date as soon as practicable in order to allow
additional time for the Company to provide updated information to the
shareholders regarding the Agreement and Plan of Merger, dated as of February
8, 2013, by and among Decade Sunshine Limited, Decade Sunshine Merger Sub and
the Company, as amended by Amendment No. 1 to the Agreement and Plan of
Merger, dated as of April 24, 2013 (the "Amended Merger Agreement"). Apart
from the adjournment of the EGM, no other business was conducted at EGM. The
Company expects to file with the Securities and Exchange Commission (the
"SEC") and send to shareholders promptly a supplement to the definitive proxy
statement dated March 25, 2013 relating to the Amended Merger Agreement.The
Company will give notice to shareholders of the date on which the adjourned
EGM will be reconvened as soon as a date is selected.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused
on researching, developing, manufacturing and marketing biopharmaceutical
products primarily in China. Its focus is on addressing large markets with
significant unmet medical needs in nephrology, oncology, supportive cancer
care, inflammation and infectious diseases. With headquarters and
GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over
800 people. Shares trade in the form of ADSs on the NASDAQ Global Market
under the ticker symbol "SSRX". Please see www.3SBio.com for more
information.

Safe Harbor Statement

This press release and related Company disclosures may include certain
statements that are not descriptions of historical facts, but are
forward-looking statements. Such statements include, among others, those
concerning expected benefits and costs of the proposed transaction; management
plans relating to the transaction; the expected timing of various aspects of
the transaction; the parties' ability to complete the transaction considering
the various closing conditions, as well as all assumptions, expectations,
predictions, intentions or beliefs about future events. Forward-looking
statements can generally be identified by the use of forward-looking
terminology such as "anticipate," "proposed," "will," "intend," "may,"
"believes," "expects" or similar expressions. Such information is based upon
expectations of the Company that were reasonable when made. Risks and
uncertainties that may cause actual outcome to differ from the forward-looking
statements may include: whether sufficient number of shareholders will view
the terms favorably, and vote to approve this transaction; whether Decade
Sunshine Limited will secure and receive full financing; whether all the
closing conditions and other terms of the transaction documents will be duly
complied with or fulfilled; future business decisions of various parties, and
other risks and uncertainties discussed in the documents filed or to be filed
with the SEC by the Company, particularly the Schedule 13E-3 transaction
statement and the proxy statement. These forward-looking statements reflect
the Company's expectations as of the time of this press release. The Company
undertakes no ongoing obligation, other than that imposed by law, to update
these statements.

For investor and media inquiries, please contact:

Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
ir@3SBio.com

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
ir@3SBio.com



SOURCE 3SBio Inc.

Website: http://www.3sbio.com